🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for GI Cancer

A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers NCT06568016NA2 sites📍 Los Angeles📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Best Practice, Communication Intervention, Communication Intervention, Coordination, Educational Intervention Precision Navigation to Improve Community Cancer Screening Participation NCT07676383NA3 sites📍 Huaihua📍 Shaoyang📍 Yongzhou Hunan Cancer Hospital · Tests: Precision Navigation Intervention, Usual Health Education Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites📍 San Francisco📍 Walnut Creek University of California, San Francisco · Tests: Radiation Therapy (RT) KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) NCT07406633Phase 217 sites📍 Los Angeles📍 Jacksonville📍 Miami Kumquat Biosciences Inc. · Tests: KQB198, Imatinib (Gleevec) Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy NCT07456852Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Capecitabine, Diltiazem Hydrochloride, Electrocardiogram, Fluorouracil Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy NCT06040801NA1 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: Frailty intervention measures Establishment of a Biological Collection to Develop Translational Preclinical Models for the Study of Tumors and Diseases of the Gastrointestinal Tract NCT07782203NA1 site📍 Strasbourg University Hospital, Strasbourg, France · Tests: biopsy YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. NCT06337760n/a1 site📍 Milan European Institute of Oncology BOLSTER: Learning New Skills to Thrive NCT06936878NA2 sites📍 Boston📍 Houston Dana-Farber Cancer Institute · Tests: BOLSTER Program Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models NCT06002425NA7 sites📍 Duarte📍 Jiangmen📍 Zhuhai Chinese Academy of Sciences · Tests: Clinician-Directed Treatment Plan, ChatGPT-Assisted Treatment Plan Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies NCT03539822Phase 1, Phase 22 sites📍 Westwood📍 Pittsburgh Anwaar Saeed · Tests: Cabozantinib, Durvalumab, Tremelimumab Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study NCT05984576n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Reirradiation Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NCT07483658NA4 sites📍 Gatineau📍 Montreal📍 Montreal CHU de Quebec-Universite Laval · Tests: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radi… EUS Guided HVA and PVA for Circulating Tumor DNA in Patients NCT04782557NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: EUS-guided portal vein and hepatic vein aspiration Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas NCT04268121Phase 214 sites📍 Amiens📍 Besançon📍 Clichy GERCOR - Multidisciplinary Oncology Cooperative Group · Tests: Neoadjuvant treatment, Adjuvant treatment Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers NCT07415564NA1 site📍 Tucson University of Arizona · Tests: Symptom Management and Survivorship Handbook + Coaching, Symptom Management and Survivorship Handbook Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not NCT07273409NA4 sites📍 Gothenburg📍 Lund📍 Stockholm Uppsala University · Tests: Debulking surgery Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors NCT06908629NA1 site📍 Detroit Barbara Ann Karmanos Cancer Institute · Tests: Implementation of social determinants of health screening and referral Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) NCT05066139NA1 site📍 Strasbourg Centre Paul Strauss · Tests: EPODIG-G program (coordination of supportive care) DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients NCT05274048Phase 13 sites📍 Palo Alto📍 Buffalo📍 Philadelphia Fox Chase Cancer Center · Tests: Neratinib Pill, Fam-Trastuzumab Deruxtecan-Nxki (TDxD) Tier Palliative Care For Patients With Advanced Heart Failure or Cancer NCT07391956NA5 sites📍 Astoria📍 New York📍 New York Icahn School of Medicine at Mount Sinai · Tests: Tier-Palliative Care, Community Health Worker Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy NCT00991094n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Quality-of-Life Assessment, Questionnaire Administration Pathogenesis of Postoperative Infections and Biomarkers for Early Diagnosis of it NCT06513598n/a2 sites📍 Vilnius📍 Vilnius National Cancer Center Affiliate of Vilnius University Hosp… · Tests: Major visceral surgery for gastrointestinal cancer Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan NCT07426146n/a2 sites📍 Gengma County📍 Lincang Shanghai First Maternity and Infant Hospital · Tests: low glycemic index-high fiber Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer NCT04530890NA1 site📍 Poitiers Poitiers University Hospital · Tests: Blood samples A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Engineering Tumor Infiltrating Lymphocytes A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers NCT05789485Phase 28 sites📍 Hartford📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: structured treadmill walking Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer NCT05780684NA1 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: FOX dose-escalation algorithm
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy